Gustav Christensen

President at

Phytera, Inc.

78 year

59 connections

Health Technology

Finance

Consumer Services

Profile

Gustav A. Christensen is currently Chairman at Morphic Therapeutic, Inc. and President, Treasurer & Director at Phytera, Inc. Former roles include Chairman at Morphic Holding, Inc. (2016–2024), Independent Director at Generation Bio Co. (2017–2026), President, Chief Executive Officer & Director at Dyax Corp.
(2011–2016), Managing Director at Apeiron Partners LLC (2005–2007), Vice President-Business Development at Genetics Institute LLC (1983–1988), Vice President-Operations Fenwal Laboratories at Baxter International, Inc. (1976–1983), Chairman at Alpha-Beta Technology, Inc., President at ImmuLogic Pharmaceutical Corp., Advisor at BioVentures Investors, and Member-Management Board at Alantos Pharmaceuticals AG.
Education includes graduate studies at the University of Aarhus and an MBA from Harvard Business School.

Gustav Christensen active positions

Companies	Position	Start
Phytera, Inc. Phytera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops plant-based and marine-based pharmaceuticals	President	-
Morphic Therapeutic, Inc. Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors	Chairman	-

All active positions of Gustav Christensen

Former positions of Gustav Christensen

Companies	Position	End
GENERATION BIO CO.	Director/Board Member	06/02/2026
MORC HOLD	Chairman	16/08/2024
DYAX CORP.	Chief Executive Officer	22/01/2016
BioVentures Investors BioVentures Investors Investment ManagersFinance BioVentures invests in companies located in the United States. The firm focuses on the health care and medtech sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 25 million. It also takes a seat on the board of directors.	Private Equity Investor	31/03/2009
Apeiron Partners LLC Apeiron Partners LLC Investment ManagersFinance Provides investment advice	Corporate Officer/Principal	01/01/2007

See the detail of Gustav Christensen's experience

Training of Gustav Christensen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gustav Christensen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
Baxter International, Inc. Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services	Health Technology
Genetics Institute LLC Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Health Technology
ImmuLogic Pharmaceutical Corp. ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Alpha-Beta Technology, Inc. Alpha-Beta Technology, Inc. Electronic ComponentsElectronic Technology Discovers, develops and commercialization of novel carbohydrate-based products	Electronic Technology
Dyax Corp. Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics	Health Technology
Phytera, Inc. Phytera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops plant-based and marine-based pharmaceuticals	Commercial Services
BioVentures Investors BioVentures Investors Investment ManagersFinance BioVentures invests in companies located in the United States. The firm focuses on the health care and medtech sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 25 million. It also takes a seat on the board of directors.	Finance
University of Aarhus University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Alantos Pharmaceuticals AG Alantos Pharmaceuticals AG BiotechnologyHealth Technology Develops and manufactures molecule pharmaceuticals for arthritic and metabolic diseases	Health Technology
Harvard Business School Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Apeiron Partners LLC Apeiron Partners LLC Investment ManagersFinance Provides investment advice	Finance
Morphic Therapeutic, Inc. Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors	Health Technology
Morphic Holding, Inc. Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs	Health Technology
Generation Bio Co. Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines	Health Technology